Skip to main content

Table 3 Demographics and clinical information (N = 503)

From: Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using Combivent Respimat

Characteristic

n (%)

Sex

 Male

215 (42.7)

 Female

288 (57.3)

Age

 40 to 50 years

108 (21.5)

 51 to 60 years

181 (36.0)

 61 to 70 years

159 (31.6)

 71 to 75 years

55 (10.9)

Race

 White

445 (88.5)

 Black/African American

33 (6.6)

 American Indian or Alaska Native

7 (1.4)

 Native Hawaiian

1 (0.2)

 Other Pacific Islander

0 (0.0)

 Asian

4 (0.8)

 Other

12 (2.4)

Highest grade completed

 Less than High School

74 (14.7)

 High School Diploma or equivalent (e.g., GED)

182 (36.2)

 Some College

119 (23.7)

 College Degree

82 (16.3)

 Professional or advanced degree

46 (9.1)

Employment status

 Employed full-time

114 (22.7)

 Employed part-time

28 (5.6)

 Not employed or retired

358 (71.2)

Number of Combivent Respimat prescriptions over past 8 months

 2 inhalers

143 (28.4)

 3 inhalers

100 (19.9)

 4 or more inhalers

260 (51.7)

Taking Combivent Respimat for:

 Chronic obstructive pulmonary disease only

236 (46.9)

 Asthma only

110 (21.9)

 Other lung disease only

41 (8.2)

 More than one disease

116 (23.1)

Using the Combivent Respimat for...

 Less than 3 months

68 (13.5)

 3 to 6 months

188 (37.4)

 7 to 12 months

179 (35.6)

 I don’t know

68 (13.5)

Take Combivent Respimat...

 Once daily

20 (4.0)

 Twice daily

120 (23.9)

 Other

95 (18.9)

 As needed

268 (53.3)

Ever used other inhalers?

 Yes

426 (84.7)

 No

77 (15.3)

Ever used nebulizer

 Yes

310 (61.6)

 No

157 (31.2)

 I don’t know

36 (7.2)